1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Bioqual, Inc.

Bioqual, Inc.

BIOQ
Bioqual, Inc.US flagOther OTC
32.50
USD
- -
- -
29.07MMarket Cap

Total Valuation

Bioqual, Inc. carries a market capitalization of 29.07M, placing it among publicly traded companies globally. Its enterprise value stands at 1.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap29.07M
Enterprise Value1.82M

Share Statistics

Bioqual, Inc. currently has 896,000.00 shares outstanding.

Shares Outstanding896,000.00
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Bioqual, Inc. trades at a trailing price-to-earnings ratio of 8.15. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at 1.28.

PE Ratio8.15
PS Ratio0.23
PB Ratio1.28
P/TBV Ratio0.52
P/FCF Ratio2.71
P/OCF Ratio2.71

Enterprise Valuation

On an enterprise value basis, Bioqual, Inc. trades at an EV/EBITDA multiple of 0.92 and an EV/FCF ratio of 0.88. The EV/Sales ratio of 0.08 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1.57 provides insight into valuation relative to core operating earnings.

EV / Sales0.08
EV / EBITDA0.92
EV / EBIT1.57
EV / FCF0.88

Financial Position

Bioqual, Inc. maintains a current ratio of 3.75, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities.

Current Ratio3.75
Quick Ratio3.62
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage19,081.58

Financial Efficiency

Bioqual, Inc. posts a return on equity of 16.69 and a return on invested capital of 6.52.

Return on Equity (ROE)16.69
Return on Assets (ROA)5.29
Return on Invested Capital (ROIC)6.52
Return on Capital Employed (ROCE)16.69
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Bioqual, Inc. has paid 479,142.00 in income taxes, reflecting an effective tax rate of 41.23.

Income Tax479,142.00
Effective Tax Rate41.23

Stock Price Statistics

Bioqual, Inc.'s stock has declined approximately -27.77778% over the past 52 weeks. The 50-day moving average sits at 36.49, while the 200-day moving average is 38.52.

Beta (5Y)N/A
52-Week Price Change-27.77778%
50-Day Moving Average36.49
200-Day Moving Average38.52
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Bioqual, Inc. generated 23.89M in revenue and converted that into 683,897.00 in net income, yielding earnings per share of 0.76. EBITDA reached 1.97M, while operating income came in at 1.16M.

Revenue23.89M
Gross Profit5.07M
Operating Income1.16M
Pretax Income1.16M
Net Income683,897.00
EBITDA1.97M
EBIT1.16M
Earnings Per Share (EPS)0.76

Balance Sheet

Total book value stands at 4.34M, with working capital of 7.97M providing operational flexibility.

Cash & Cash Equivalents3.76M
Total DebtN/A
Net Debt-3.76M
Equity (Book Value)4.34M
Book Value Per Share4.83
Working Capital7.97M

Cash Flow

Bioqual, Inc. produced 2.06M in operating cash flow over the past twelve months.

Operating Cash Flow2.06M
Capital ExpendituresN/A
Free Cash Flow2.06M
FCF Per Share2.29

Margins

Bioqual, Inc. operates with a gross margin of 21.21, reflecting its pricing power and cost economics. The operating margin of 4.85 and net profit margin of 2.86 provide insight into operational efficiency.

Gross Margin21.21
Operating Margin4.85
Pretax Margin4.86
Profit Margin2.86
EBITDA Margin8.23

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield3.44
FCF Yield36.89

Stock Splits

Bioqual, Inc.'s most recent stock split took place on October 30, 1997 with a 6:1 split ratio.

Last Split Date10/30/1997
Split Ratio6:1

Scores

Bioqual, Inc. posts an Altman Z-Score of 4.09, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.09